175 related articles for article (PubMed ID: 22674100)
1. Preventing overcorrection of hyponatraemia with desmopressin.
Tomlin SC; Williams R; Riley S
BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674100
[TBL] [Abstract][Full Text] [Related]
2. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
Ochiai H; Uenishi E
Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
[TBL] [Abstract][Full Text] [Related]
3. Managing hyponatraemia secondary to primary polydipsia: beware too rapid correction of hyponatraemia.
Boehm E; Kumar S; Nankervis A; Colman P
Intern Med J; 2017 Aug; 47(8):956-959. PubMed ID: 28782208
[TBL] [Abstract][Full Text] [Related]
4. DDAVP to prevent rapid correction in hyponatremia.
Goldszmidt MA; Iliescu EA
Clin Nephrol; 2000 Mar; 53(3):226-9. PubMed ID: 10749304
[TBL] [Abstract][Full Text] [Related]
5. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
MacMillan TE; Tang T; Cavalcanti RB
Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
[TBL] [Abstract][Full Text] [Related]
7. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
[TBL] [Abstract][Full Text] [Related]
8. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
[TBL] [Abstract][Full Text] [Related]
9. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP
BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
[TBL] [Abstract][Full Text] [Related]
10. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
Velez JC; Dopson SJ; Sanders DS; Delay TA; Arthur JM
Nephrol Dial Transplant; 2010 May; 25(5):1524-31. PubMed ID: 20064953
[TBL] [Abstract][Full Text] [Related]
11. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
[TBL] [Abstract][Full Text] [Related]
12. [Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?].
ten Doesschate T; Reichert LJ; Claassen JA
Tijdschr Gerontol Geriatr; 2010 Dec; 41(6):256-61. PubMed ID: 21229778
[TBL] [Abstract][Full Text] [Related]
13. Osmotic demyelination syndrome following slow correction of hyponatraemia.
Saunders I; Williams DM; Ruslan AM; Min T
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34373247
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
MacMillan TE; Cavalcanti RB
Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
Rajendran R; Grossman AB; Kar P
Endocr J; 2012; 59(10):903-9. PubMed ID: 22785335
[TBL] [Abstract][Full Text] [Related]
17. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
Spatenkova V; Bradac O; Skrabalek P
J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
[TBL] [Abstract][Full Text] [Related]
18. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.
Behan LA; Sherlock M; Moyles P; Renshaw O; Thompson CJ; Orr C; Holte K; Salehmohamed MR; Glynn N; Tormey W; Thompson CJ
Eur J Endocrinol; 2015 Mar; 172(3):243-50. PubMed ID: 25430399
[TBL] [Abstract][Full Text] [Related]
19. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
Choi EY; Park JS; Kim YT; Park SY; Kim GH
Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative Use of Desmopressin for Treatment of Profound Hyponatremia in the Setting of Emergency Surgery: A Case Report.
Watterworth BS; Noorani RJ
A A Pract; 2018 Jul; 11(2):54-56. PubMed ID: 29634545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
